SE0002211D0 - Methods and compositions for prevention of myopia - Google Patents

Methods and compositions for prevention of myopia

Info

Publication number
SE0002211D0
SE0002211D0 SE0002211A SE0002211A SE0002211D0 SE 0002211 D0 SE0002211 D0 SE 0002211D0 SE 0002211 A SE0002211 A SE 0002211A SE 0002211 A SE0002211 A SE 0002211A SE 0002211 D0 SE0002211 D0 SE 0002211D0
Authority
SE
Sweden
Prior art keywords
myopia
prevention
prostaglandins
compositions
methods
Prior art date
Application number
SE0002211A
Other languages
Swedish (sv)
Inventor
Johan Stjernschantz
Bahram Resul
Original Assignee
Synphora Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synphora Ab filed Critical Synphora Ab
Priority to SE0002211A priority Critical patent/SE0002211D0/en
Publication of SE0002211D0 publication Critical patent/SE0002211D0/en
Priority to PCT/SE2001/001339 priority patent/WO2001095913A1/en
Priority to AU2001264522A priority patent/AU2001264522A1/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Exogenous prostaglandins and derivatives of prostaglandins as well as anti-inflammatory agents blocking prostaglandin synthesis are disclosed as useful for the prevention of the development of myopia. The prostaglandins should preferentially be administered topically on the eye, whereas the anti-inflammatory agents may be administered topically on the eye or orally. The administration may be continuous or intermittent.
SE0002211A 2000-06-13 2000-06-13 Methods and compositions for prevention of myopia SE0002211D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0002211A SE0002211D0 (en) 2000-06-13 2000-06-13 Methods and compositions for prevention of myopia
PCT/SE2001/001339 WO2001095913A1 (en) 2000-06-13 2001-06-13 Methods and compositions for the prevention of myopia
AU2001264522A AU2001264522A1 (en) 2000-06-13 2001-06-13 Methods and compositions for the prevention of myopia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0002211A SE0002211D0 (en) 2000-06-13 2000-06-13 Methods and compositions for prevention of myopia

Publications (1)

Publication Number Publication Date
SE0002211D0 true SE0002211D0 (en) 2000-06-13

Family

ID=20280076

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0002211A SE0002211D0 (en) 2000-06-13 2000-06-13 Methods and compositions for prevention of myopia

Country Status (3)

Country Link
AU (1) AU2001264522A1 (en)
SE (1) SE0002211D0 (en)
WO (1) WO2001095913A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01013257A (en) * 2001-12-18 2003-06-25 Arturo Jimenez Bayardo Rofecoxib ophthalmic suspension for the treatment of ocular inflammation and pain.
US7074827B2 (en) 2002-10-24 2006-07-11 Sucampo Ag (Usa) Inc. Method for treating ocular hypertension and glaucoma
WO2005051413A2 (en) * 2003-11-26 2005-06-09 Novartis Ag Disease associated genes
CN102078614B (en) * 2010-12-27 2012-07-25 温州医学院眼视光研究院 Method for inhibiting shortsightedness and application of adenylate cyclase inhibitor as medicament for inhibiting shortsightedness
EP2694077A4 (en) * 2011-04-07 2015-01-21 Sucampo Ag Method for treating asthenopia
US20160067238A1 (en) * 2013-05-06 2016-03-10 Philip Wu Pharmaceutical composition and uses thereof
TWI658828B (en) * 2014-10-31 2019-05-11 中國醫藥大學 Pharmaceutical composition for soothing and reducing myopia, and preparation method and application thereof
CN105998030A (en) * 2016-05-17 2016-10-12 温州医科大学 Application of prostaglandin F2a receptor stimulant in preparation of drug for inhibiting myopia and application method of prostaglandin F2a receptor stimulant
CN116726006A (en) 2016-08-19 2023-09-12 阿拉西斯医药公司 Ophthalmic pharmaceutical compositions and related uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519030A (en) * 1993-10-07 1996-05-21 Senju Pharmaceutical Co., Ltd. Method for prophylaxis and treatment of myopia
AU5805998A (en) * 1997-01-02 1998-07-31 Allergan Sales, Inc. Method for changing the refractive power of an eye
CA2276287C (en) * 1997-01-06 2007-10-30 Klaus Trier Aps Screening method for compounds active in treating myopia and hypermetropia
WO1999018970A1 (en) * 1997-10-14 1999-04-22 Senju Pharmaceutical Co., Ltd. Preventives and remedies for ophthalmic circulatory disturbance

Also Published As

Publication number Publication date
AU2001264522A1 (en) 2001-12-24
WO2001095913A1 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
FR16C1001I2 (en) "2-OXO-1-PYRROLIDINE DERIVATIVE AND ITS PHARMACEUTICAL APPLICATIONS"
NO20025601D0 (en) Arylmethylamine derivatives for use as tryptase inhibitors
EE05287B1 (en) The so-called clopentanoindoles, their use in the manufacture of a medicament and the pharmaceutical composition containing them
TR200200579T2 (en) Amino-thyrazolpyridine derivatives.
YU69902A (en) New piperazine derivatives
RS50140B (en) Percyquinnin, a process for its production, and its use as a pharmaceutical
BRPI0418245A (en) Nitroxy Prostaglandin Derivatives
BR0215184A (en) orally active taxane derivative pharmaceutical compositions having increased bioavailability
DK0738152T3 (en) Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as chemopreventive and chemotherapeutic agents for colon cancer
TR199802060T2 (en) Use of aminoisoquinolins and aminopyridine derivatives as anti-inflammatory agents.
DK1296972T3 (en) Arylmethylamine derivatives for use as tryptase inhibitors
SE0002211D0 (en) Methods and compositions for prevention of myopia
ATE360428T1 (en) ANALGESIC MEDICINAL PRODUCT
TR200001452T2 (en) Biphenylamidine derivatives.
NO20013414D0 (en) New use of melagatran
NO20031410L (en) Use of distamycin derivatives for the manufacture of drugs
EE200100066A (en) Use of Sodium Chloride to Reduce Gastrointestinal Side Effects Due to Administration of Camptothecin Derivatives
WO2002072105A3 (en) Improved prostanoid therapies for the treatment of glaucoma
EE200200098A (en) Treatment of migraine by administration of alpha-lipoic acid or derivatives thereof
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
NO964497L (en) Means for the treatment of cor pulmonale
AR027349A1 (en) DERIVATIVES OF HETEROCICLIC AMIDAS
ATE290374T1 (en) IGA PRODUCTION INHIBITORS
DK1115687T3 (en) 5,6-Dihydronaphthalenyl derivatives with retinoid-like activity